Try GOLD - Free
India-China rapprochement: A season of wishful thinking?
Mint Chennai
|September 05, 2025
The record doesn't show Beijing as a reliable partner for New Delhi
When pictures emerged from the Shanghai Cooperation Organisation (SCO) summit in Tianjin of Prime Minister Narendra Modi holding hands with China's Xi Jinping and Russia's Vladimir Putin, there was no question that this was a deliberate choice—a statement that India will give the authoritarians to its north yet another chance to show that they are worthy of trust.
This is a massive policy shift in a relatively short time. Just five years ago, Chinese and Indian soldiers were fighting each other on the frozen heights of the Himalayan border they dispute. They stayed eyeball-to-eyeball while New Delhi slowly cut connections with Beijing—banning Chinese investment, throwing out TikTok and cultivating an independent constituency in the Global South. Indian diplomacy presented the country as looking outward to the 'Indo-Pacific,' a vast maritime area defined to include the US, rather than to a 'Eurasia' dominated by continental powers like Russia and China.
If Modi now wants to reach out a hand to the leaders of Eurasia, one might assume it is entirely because India has been insulted and rejected by the US—laden with higher tariffs than almost all its peers and continually needled by President Donald Trump's advisors and officials.
This story is from the September 05, 2025 edition of Mint Chennai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
